Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.15 USD | -1.27% |
|
+21.37% | +13.65% |
Chart calendar Entrada Therapeutics, Inc.
Upcoming events on Entrada Therapeutics, Inc.
Past events on Entrada Therapeutics, Inc.
2024-06-13 09:30 am | Annual General Meeting |
2024-06-10 04:00 pm | Goldman Sachs Global Healthcare Conference - Fireside Chat |
2024-05-20 09:30 am | H.C. Wainwright BioConnect Investor Conference |
2024-05-09 12:00 am | Q1 2024 Earnings Release |
2024-03-13 07:00 am | Q4 2023 Earnings Release |
2024-03-04 09:10 am | TD Cowen Health Care Conference |
2024-02-14 02:00 pm | Oppenheimer Healthcare Life Sciences Conference |
2023-11-29 03:50 pm | Evercore ISI HealthCONx Conference |
2023-11-07 07:00 am | Q3 2023 Earnings Release |
2023-10-16 11:00 am | William Blair Innovator Series Conference |
2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
2023-09-07 09:30 am | Wells Fargo Healthcare Conference |
2023-08-08 07:00 am | Q2 2023 Earnings Release |
2023-06-14 01:40 pm | Goldman Sachs Global Healthcare Conference |
2023-06-08 09:30 am | Annual General Meeting |
2023-05-10 07:00 am | Q1 2023 Earnings Release |
2023-04-04 09:00 am | Guggenheim Genomic Medicines and Rare Disease Day |
2023-03-18 | Muscular Dystrophy Association Clinical & Scientific Conference |
2023-03-08 02:10 pm | Cowen Health Care Conference |
2023-03-06 07:00 am | Q4 2022 Earnings Release |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 129 111 16.36% | 144 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -50,0 -61,9 19.25% | -95,4 -96,3 0.96% | -0,32 -21,1 98.48% | -28,5 |
EBIT Million USD | Released Forecast Spread | 0,00 | -51,1 -59,1 13.52% | -97,2 -96,9 -0.37% | -3,16 -15,1 79.05% | -22,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -51,2 -55,2 7.32% | -94,6 -95,6 1.03% | 12,1 -0,83 1554.28% | -18,5 |
Net income Million USD | Released Forecast Spread | -26,5 | -51,2 -55,2 7.32% | -94,6 -95,6 1.03% | -6,69 -1,32 -405.39% | -20,4 |
EPS USD | Released Forecast Spread | -3,32 | -8,16 -6,25 -30.56% | -3,02 -3,07 1.47% | -0,20 -0,04 -370.59% | -0,30 |
Announcement Date | 06/08/21 | 15/03/22 | 06/03/23 | 13/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 25,3 79,3 -68.16% | 18,2 9,78 85.86% | 43,7 9,60 355.69% | 41,8 23,7 76.61% | 59,1 15,2 289.09% | 46,1 | 18,8 | 15,6 | 12,0 | 12,0 |
EBIT Million USD | Released Forecast Spread | -22,2 -20,4 -8.67% | -23,6 -22,9 -3.05% | -25,9 -24,0 -7.86% | -25,6 -26,1 2.01% | -5,78 51,8 -111.16% | -16,3 -22,9 28.71% | 14,0 -26,1 153.73% | 4,91 -7,56 164.87% | 21,1 -16,6 226.97% | 6,54 | -23,2 | -26,8 | ||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,7 -20,5 -5.71% | -23,2 -22,5 -3.02% | -25,1 -23,5 -6.97% | -24,6 -25,7 4.17% | -3,12 85,3 -103.66% | -12,1 -19,2 36.97% | 18,1 -23,2 177.87% | 9,20 -3,70 348.69% | 25,3 -17,2 247.25% | 8,30 | -18,7 | -23,8 | ||
Net income Million USD | Released Forecast Spread | -21,7 -20,5 -5.71% | -23,2 -22,5 -3.02% | -25,1 -23,5 -6.97% | -24,6 -25,7 4.17% | -6,67 85,3 -107.83% | -25,9 -19,8 -30.79% | 35,5 -23,9 248.65% | -9,54 -4,19 -127.67% | 23,5 -17,2 236.6% | 8,30 | -18,7 | -23,8 | ||
EPS USD | Released Forecast Spread | -0,69 -0,66 -4.55% | -0,74 -0,72 -2.78% | -0,80 -0,75 -6.67% | -0,78 -0,83 6.02% | -0,21 2,57 -108.19% | -0,78 -0,60 -29.28% | 1,02 -0,71 242.99% | -0,28 -0,12 -128.57% | 0,68 -0,56 221.43% | 0,39 | -0,61 | -0,72 | -0,89 | -0,93 |
Announcement Date | 12/05/22 | 11/08/22 | 07/11/22 | 06/03/23 | 10/05/23 | 08/08/23 | 07/11/23 | 13/03/24 | 07/05/24 | - | - | - | - | - |
Past sector events for Entrada Therapeutics, Inc.
2024-07-11 04:00 pm | NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release |
2024-07-04 | PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release |
2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TRDA Stock
- Calendar Entrada Therapeutics, Inc.